Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
Articles
Alternative - Cleantech
Alternative Energy
Base Metals
Battery Metals
Biotechnology / Pharmaceuticals
Clean Energy
Cobalt / Lithium / Manganese
Critical Metals
Cryptocurrency / Blockchain
Gold
Healthcare Services
Helium
Life Sciences Tools & Diagnostics
Medical Devices
Oil & Gas - Equipment
Oil & Gas - Exploration & Production
Oil & Gas - Services
PGM - Platinum Group Metals
Regenerative Medicine
Renewable - Geothermal
Renewable - Solar
Renewable - Wind
Robotics
Silver
Special Situations
Technology
Uranium
Disclosures
×
UroGen Pharma Ltd.
URGN:NASDAQ
Streetwise Company Fact Sheet
2025/6/22 23:51:01
(URGN:NASDAQ)
Analyst coverage
TD Cowen
—
Dr. Tara Bancroft
Goldman Sachs
—
Paul Choi
Oppenheimer & Co.
—
Dr. Leland Gershell
Ladenburg Thalmann
—
Matthew Kaplan
H.C. Wainwright & Co.
—
Dr. Ram Selvaraju
Streetwise Reports Articles
04/28/2025 - View Article
Streetwise - UroGen Pharma Ltd. Ownership Overview*
UroGen Pharma Ltd.
(URGN:NASDAQ)
*
Share Structure as of 4/28/2025